FEW CASES BETTER SHOW HOW U.S.China relations have deteriorated in the age of Big Data than the response Wang Jiang got when he offered, at the height of the pandemic, to set up labs for COVID-19 testing in the U.S.
Wang is a known quantity in the world of U.S. biotech. He cut his teeth as a genetics researcher at the major public research universities of Texas, Iowa, and Washington. He's now the snowy-haired, charismatic chairman of Shenzen-based BGI, the world's largest biotech company, which for decades has been collaborating with some of America's leading geneticists. BGI participated in the global effort to sequence the first human genome, formed a partnership with the Children's Hospital of Philadelphia to identify genes associated with pediatric diseases, and named an institute in China after Harvard's George Church, a gene-editing pioneer, who continues to work with the company.
But Wang's offer ran afoul of the National Counterintelligence and Security Center, which issued a stark warning: "Foreign powers can collect, store and exploit biometric information from COVID tests." The Trump Administration's top U.S. counterintelligence official, Bill Evanina, later told 60 Minutes that the labs were "modern-day Trojan horses," an effort by the Chinese government to establish a "foothold" to bring in equipment, collect DNA and start "mining your data." No one in the U.S. took BGI up on its offer.
Diese Geschichte stammt aus der September 16, 2022-Ausgabe von Newsweek US.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der September 16, 2022-Ausgabe von Newsweek US.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
John David Washington
FOR JOHN DAVID WASHINGTON, BRINGING NETFLIX'S THE PIANO LESSON (November 22) from stage to screen was a family affair.
A Walk in the Parks
Jim O'Heir shares his memories of the hit NBC mockumentary and its cast's hopes of a reunion
Philomena Cunk
PHILOMENA CUNK IS JUST AS SURPRISED AS anyone else at her own popularity.
SOLVING THE PLASTIC PROBLEM
PLASTIC WASTE IS HARMING ANIMALS AND OUR PLANET. CAN THE DAMAGE BE UNDONE?
'I Was Struck by How Humbled and Insignificant I Felt'
An explorer says coming face-to-face in the wild with a grizzly and her cubs changed his perspective on life
Has AI Turned On Health Care?
Hospitals hoped artificial intelligence would lighten their staff's workload, but the same tech could be to blame as insurance firms increasingly deny Medicare Advantage claims
The Next Phase of War
After thousands of elite soldiers from North Korea joined Vladimir Putin’s forces against Ukraine, how has this latest move affected the conflict?
Saying No to Trump and Men
The election has led some women to boycott relationships and sex
My Fight for Equality and Justice
It will take more than just science to end AIDS. Inclusion, empathy and compassion are essential, too
NEW WORLD ORDER
HOW LEADERS ACROSS THE GLOBE ARE REACTING TO DONALD TRUMP'S REELECTION AS U.S. PRESIDENT